Back to BMY Stock Lookup

BMY Related Mergers and Acquisitions

Aug 9, 2012 07:46 AM Bristol-Myers (BMY), AstraZeneca (AZN) Make Initial $3.2B Payment to Amylin Pharma; AstraZeneca Exercises Rights Option

Aug 1, 2012 07:34 AM Bristol-Myers Squibb (BMY) Reports Waiting Period to Acquire Amylin Pharmaceuticals (AMLN) Expired

Jul 10, 2012 07:33 AM Bristol-Myers Squibb (BMY) Commences $31/Share Cash Tender for Amylin (AMLN)

Jul 2, 2012 03:10 PM Barclays on AstraZeneca (AZN): Acquisition of AMLN Makes Strategic Sense but High Price Tag

Jun 30, 2012 09:57 AM Bristol-Myers Squibb (BMY) Acquires Amylin (AMLN) for $31/Share

Jun 5, 2012 06:57 AM Amylin (AMLN) Bidding Intensifies; Sale Expected in July

May 25, 2012 02:01 PM Amylin (AMLN) Shares Jump as Bids Due Today, Sanofi (SNY), Merck (MRK) Said to Make First-Round Bids

May 15, 2012 08:35 AM Amylin (AMLN) Attracting a Host of Other Suitors, Shares Rise

Apr 23, 2012 07:53 AM Amylin (AMLN) Shares Pop on New M&A Chatter (BMY) (AZN)

Apr 4, 2012 08:13 AM Icahn Sends Letter to Amylin (AMLN) Board; Says Company Should Be Sold

Mar 28, 2012 12:35 PM Analysts Expecting Higher Bids for Amylin (AMLN)

Mar 28, 2012 10:00 AM UPDATE: Amylin (AMLN) Rejected $22/Share Bid from Bristol-Myers (BMY)

Mar 28, 2012 09:43 AM Amylin (AMLN) Won't Comment on Takeover Reports

Mar 28, 2012 09:21 AM Amylin (AMLN) said to have rejected a $3.5B bid from Bristol-Myers (BMY) -Bloomberg

Feb 13, 2012 05:04 PM Bristol-Myers Squibb (BMY) Completes Inhibitex (INHX) Acquisition

Feb 3, 2012 07:31 AM Bristol-Myers Squibb (BMY) Moves One Step Closer to Completing Inhibitex (INHX) Acquisition

Jan 13, 2012 07:33 AM Bristol-Myers Squibb (BMY) Commences $26/Share Tender for Inhibitex (INHX)

Jan 7, 2012 11:16 PM Bristol-Myers (BMY) Acquires Inhibitex (INHX) at 163% Premium

Oct 12, 2010 04:59 PM Bristol-Myers (BMY) Completes ZymoGenetics Acquisition

Oct 8, 2010 08:31 AM Bristol-Myers Squibb (BMY) Announces 94.9% of ZymoGenetics (ZGEN) Share Tendered

Sep 28, 2010 07:45 AM Bristol-Myers (BMY) Announces Expiration of HSR Waiting Period in ZymoGenetics (ZGEN) Tender

Sep 10, 2010 07:34 AM Bristol-Myers Squibb (BMY) Launches $9.75/Share Tender Offer for ZymoGenetics (ZGEN)

Sep 7, 2010 05:58 PM ZymoGenetics (ZGEN) Shares Resume Trading Up 78%

Sep 7, 2010 05:22 PM Bristol-Myers Squibb (BMY) Agrees to Acquire ZymoGenetics (ZGEN) for $9.75/Share

Sep 7, 2010 05:21 PM Bristol-Myers (BMY) to acquire Zymogenetics (ZGEN) for $9.75/share in cash

Jul 2, 2010 07:52 AM Reports Sanofi-aventis (SNY) Planning Large U.S. Acquisition

Dec 16, 2009 01:19 PM Biogen (BIIB) Must Raise Offer for Facet (FACT) to At Least $22/Share -Merriman

Sep 1, 2009 08:15 AM Bristol-Myers Squibb (BMY) Completes Tender Offer for Medarex (MEDX)

Aug 20, 2009 04:57 PM Bristol-Myers (BMY) Extends Tender Offer for Medarex (MEDX) to August 26

Jul 23, 2009 07:04 AM Bristol-Myers (BMY) Acquires Medarex (MEDX) For $16/Share

Jun 1, 2009 08:54 AM Elan (ELN) Jumps On Possible Bristol-Myers Stake

Oct 6, 2008 07:14 AM ImClone (IMCL) Enters Merger Agreement With Eli Lilly (LLY) For $70/Share

Oct 2, 2008 07:19 AM ImClone's (IMCL) Carl Icahn Issues Statement On Takeover Bid

Sep 29, 2008 09:09 AM ImClone Systems (IMCL) Announces $70/Share Offer From Larger Phama

Sep 23, 2008 03:19 PM ImClone Systems (IMCL) Chairman Carl Icahn Sends Letter to Bristol-Myers

Sep 23, 2008 07:34 AM Bristol-Myers (BMY) Lifts Takeover Offer On ImClone (IMCL) to $62

Sep 10, 2008 10:19 AM Analyst Expects Immediate $70/Share Offer for ImClone (IMCL) from Bristol-Myers Following News

Sep 10, 2008 08:49 AM ImClone (IMCL) Tells Bristol-Myers (BMY) $60/Sh Offer Is Inadequate; Says $70/Sh Offer On the Table From Another

Aug 4, 2008 09:05 AM ImClone (IMCL) Said Bristol-Myers' (BMY) Offer Substantially Undervalues The Company

Jul 31, 2008 07:56 AM Bristol-Myers (BMY) Offers $60/Share for ImClone (IMCL) In Letter To Icahn

Jul 31, 2008 07:52 AM Imclone Systems (IMCL) holder Bristol-Myers Squibb Co. (BMY) confirms $60 per share offer.

May 29, 2008 08:43 AM Bristol-Myers Squibb (BMY) Confirms Offer To Buy Kosan Biosciences (KOSN) for $5.50/Share

May 2, 2008 04:49 PM Bristol-Myers Squibb (BMY) Sells its ConvaTec Business Unit for $4.1 Billion

May 2, 2008 04:19 PM Nordic Capital Fund VII and Avista Capital Partners Agree to Acquire Bristol-Myers Squibb ConvaTec Business for approximately $4.1 Billion

Jan 22, 2008 08:17 AM Bristol-Myers Squibb (BMY) Launches Sell Of Its ConvaTec

Dec 17, 2007 08:44 AM Bristol-Myers (BMY) Sells Medical Imaging Biz for $525M

Sep 24, 2007 09:05 AM Bristol-Myers Squibb (BMY) Acquires Privately Held Adnexus Therapeutics for $430M

May 31, 2007 11:37 AM Bristol-Myers (BMY) Pleads Guilty in DoJ Action, Sanofi (SNY) Not Fined; Merger Talks May be Renewed

Feb 12, 2007 08:00 AM Reports Sanofi-Aventis (SNY) Ended Talks to Acquire Bristol-Myers Squibb (BMY)

Jan 29, 2007 07:25 AM Bristol-Myers Squibb (BMY) Higher on Sanofi-Aventis (SNY) Merger Rumor

Back to BMY Stock Lookup